Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Hubei Gedian Humanwell Pharmaceutical Testosterone Enanthate

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Testosterone Enanthate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 389Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theramex Announces Agreement to Acquire the European Rights to Duphaston
    Theramex Announces Agreement to Acquire the European Rights to Duphaston

    10 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231002698068/en

    BUSINESSWIRE
    10 Oct 2023
    Share Share
    Theramex Enters Into Agreement With Radius Health to Commercialise ELADYNOS
    Theramex Enters Into Agreement With Radius Health to Commercialise ELADYNOS

    20 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230308005585/en

    BUSINESSWIRE
    20 Mar 2023
    Share Share
    Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland
    Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland

    13 Sep 2022

    // PHARMAPHORUM

    https://pharmaphorum.com/news/scottish-medicines-consortium-accepts-theramex-bijuve-hrt/

    PHARMAPHORUM
    13 Sep 2022
    Share Share
    Theramex Announces EC Marketing Authorization for Yselty in Uterine Fibroids
    Theramex Announces EC Marketing Authorization for Yselty in Uterine Fibroids

    17 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220617005176/en

    BUSINESSWIRE
    17 Jun 2022
    Share Share
    Theramex Launches Non-hormonal Femarelle® on the 12th of May
    Theramex Launches Non-hormonal Femarelle® on the 12th of May

    09 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220506005347/en

    BUSINESSWIRE
    09 May 2022
    Share Share
    Theramex Supports the IOF SCOPE 2021 Recommendations and Call to Action
    Theramex Supports the IOF SCOPE 2021 Recommendations and Call to Action

    21 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220321005530/en

    BUSINESSWIRE
    21 Mar 2022
    Share Share